OrbusNeich Announces Significant Developments in Healing Clinical Program With Genous Bio-Engineered Stent
19th Sep 2005, 14:53 GMT
HONG KONG, HOEVELAKEN, The Netherlands, and FORT LAUDERDALE, FL., 9/19/2005 /PRNewswire/ The interim results of the HEALING II study announced in May at the Paris Course on Revascularization have led to key clinical program developments, namely the design of the upcoming HEALING III randomized study and the start of the e-HEALING internet based registry.
Latest news from Radiology News from myHealthcareNews.com:
- Genzyme increasing R&D presence in San Antonio area
- Eisai Breaks Ground for New Oncology Facility in Research Triangle Park
- Ashok Gupta, MD Joins the Physician Team at Desert Radiologists
- AMICAS Offers Free PACS Webinar for RSNA Attendees
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
- Groundbreaking for Cancer Center on Premier Healh Campus - Middletown
- BSD Medical Sends Message of Hope at Largest Conference of US Radiation Oncologists
- Volcano to Offer 7.5M Shares
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies.
- Adherex Reports Q3 2006 Financial Results